DAVID JAY SCHURMAN
Medical Practice at Blake Wilbur Dr, Palo Alto, CA

License number
California G16975
Category
Medical Practice
Type
Adult Reconstructive Orthopaedic Surgery
Address
Address
900 Blake Wilbur Dr, Palo Alto, CA 94304
Phone
(650) 725-6798
(650) 723-6396 (Fax)

Professional information

David J Schurman Photo 1

Dr. David J Schurman - MD (Doctor of Medicine)

Procedures:
Anterior Cruciate Ligament (Acl) Surgeries, Arthrocentesis, Arthroplasty, Arthroscopy, Aspiration, Carpal Tunnel Release, Cortisone Injection, Discectomy, Endoscopic Therapy, Endoscopy
Hospitals:
STANFORD UNIVERSITY MEDICAL CENTER
450 Broadway St, Redwood City 94063
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
STANFORD UNIVERSITY MEDICAL CENTER
450 Broadway St, Redwood City 94063
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical Schools
Columbia University / College of Physicians And Surgeons
Graduated: 1965


David Jay Schurman Photo 2

David Jay Schurman, Stanford CA

Specialties:
Orthopaedic Surgery, Adult Reconstructive Orthopaedic Surgery
Work:
Stanford University
300 Pasteur Dr, Stanford, CA 94305
Education:
Columbia University (1965)


David Schurman Photo 3

Method For In Vivo Ex Vivo And In Vitro Repair And Regeneration Of Cartilage And Collagen And Bone Remodeling

US Patent:
6528052, Mar 4, 2003
Filed:
Sep 29, 2000
Appl. No.:
09/677109
Inventors:
R. Lane Smith - Palo Alto CA
Dennis R. Carter - Stanford CA
David J. Schurman - Stanford CA
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Stanford CA
International Classification:
C12N 500
US Classification:
424 937
Abstract:
A method for in vivo, ex vivo and in vitro regeneration of cartilage and collagen. In vivo, ex vivo and in vitro regeneration and de novo formation of articular cartilage and collagen by intermittently applied hydrostatic pressure. The application of external interval loading consisting of repeated periods of applied hydrostatic pressure followed and interrupted by periods of recovery. The application of the intermittent hydrostatic pressure at physiological levels 5-10 MPA for an interval of 4 hours followed by a recovery period up to about 20 hours, said pressure applied to the cartilage cells in vitro, explants of cartilage ex vivo and in vivo to cartilage that remains intact within te joint space of diarthrotic joints. The interval loading results in the selective inhibition of matrix degrading enzymes, pro-inflammatory cytokines and chemokines that attract inflammatory cells into the joint cavity and in selective decrease of gene, expression of growth factors that are inhibitory to type II collagen expression.


David Schurman Photo 4

Prostheses Having Curvilinear Collars

US Patent:
6383226, May 7, 2002
Filed:
Jun 9, 1998
Appl. No.:
09/094230
Inventors:
Dennis R. Carter - Stanford CA
Jay A. Mandell - Saratoga CA
David J. Schurman - Stanford CA
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
A61F 236
US Classification:
623 2321
Abstract:
Novel prostheses, particularly femoral prostheses, are provided. The subject devices are characterized by the presence of a curvilinear collar. Also provided are methods of implanting a prosthesis in a manner sufficient to provide for a pressure profile at the collar interface in which the pressure increases from the endosteal to the periosteal surface of the bone.


David Schurman Photo 5

Method For In Vivo, Ex Vivo And In Vitro Repair And Regeneration Of Cartilage And Collagen And Bone Remodeling

US Patent:
2009017, Jul 9, 2009
Filed:
Jul 11, 2008
Appl. No.:
11/980967
Inventors:
R. Lane Smith - Palo Alto CA, US
Dennis R. Carter - Stanford CA, US
David J. Schurman - Stanford CA, US
International Classification:
C12N 5/08, C12N 5/06
US Classification:
435366, 435325
Abstract:
A method for in vivo, ex vivo and in vitro regeneration of cartilage and collagen. In vivo, ex vivo and in vitro regeneration and de novo formation of articular cartilage and collagen by intermittently applied hydrostatic pressure. The application of external interval loading consisting of repeated periods of applied hydrostatic pressure followed and interrupted by periods of recovery. The application of the intermittent hydrostatic pressure at physiological levels 5-10 MPA for an interval of hours followed by a recovery period up to about 20 hours, said pressure applied to the cartilage cells in vitro, explants of cartilage ex vivo and in vivo to cartilage that remains intact within te joint space of diarthrotic joints. The interval loading results in the selective inhibition of matrix degrading enzymes, pro-inflammatory cytokines and chemokines that attract inflammatory cells into the joint cavity and in selective decrease of gene expression of growth factors that are inhibitory to type II collagen expression.


David Schurman Photo 6

Method And Apparatus For Quantitative And Comparative Analysis Of Image Intensities In Radiographs

US Patent:
7835559, Nov 16, 2010
Filed:
Apr 27, 2007
Appl. No.:
11/741657
Inventors:
David J. Schurman - Stanford CA, US
Robert Lane Smith - Palo Alto CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Stanford CA
International Classification:
G06K 9/00, G01N 23/05
US Classification:
382128, 25039002
Abstract:
A system for determining image intensity of a radiograph includes an illuminator for providing lighting to the radiograph, an image reference standard having a predetermined color, a digital imaging device for obtaining a digital image of the radiograph and the image reference standard, a computer for receiving and storing the digital image and for executing programs, and an image analysis program being executed on the computer for providing a first image intensity value of a target area in the radiograph and a second image intensity value of the image reference standard and for computing a normalized image intensity value of the target area using the first and second image intensity values. In one embodiment, the image reference standard is an image reference standard of a black color or a white color.


David Schurman Photo 7

Method For In Vivo, Ex Vivo And In Vitro Repair And Regeneration Of Cartilage

US Patent:
7892799, Feb 22, 2011
Filed:
Aug 30, 2007
Appl. No.:
11/897911
Inventors:
Robert Lane Smith - Palo Alto CA, US
Dennis R. Carter - Stanford CA, US
David J. Schurman - Stanford CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
The United States of America as represented by the Department of Veterans Affairs - Washington DC
International Classification:
C12N 5/00
US Classification:
4351738, 424548, 424 937, 601 1, 601 2
Abstract:
A method for in vivo, ex vivo and in vitro regeneration of cartilage, collagen and bone remodeling by intermittently applied hydrostatic pressure consisting of repeated periods of applied hydrostatic pressure followed and interrupted by periods of recovery. The intermittent hydrostatic pressure is applied at physiological levels 5-10 MPA for an interval of 4 hours followed by a recovery period up to about 20 hours. The interval loading results in the selective inhibition of matrix degrading enzymes, pro-inflammatory cytokines and chemokines that attract inflammatory cells into the joint cavity and in selective decrease of gene expression of growth factors that are inhibitory to type II collagen expression.


David Schurman Photo 8

Articulated Prosthetic Knee And Method For Implanting Same

US Patent:
4358859, Nov 16, 1982
Filed:
Oct 4, 1979
Appl. No.:
6/081713
Inventors:
David J. Schurman - Stanford CA
Robert L. Piziali - Stanford CA
International Classification:
A61F 103
US Classification:
3 1911
Abstract:
An articulated knee prosthesis in which a femoral implant has a condyle section and a femoral stem that is cemented into the femur. A tibial implant carries a tibial plateau section on which is mounted a stop plate for engaging the condyle section and arresting movement of the knee beyond its fully extended position. The tibial implant includes a tibial stem that is cemented into the tibia. A pivotal connection between the two implants is positioned posteriorly of the implant and at an elevation above a lowermost point of the condyle section (when the implants are fully extended). The pivot axis of the connection and the stems are positioned with respect to each other so that upon the implantation of the implant, the patient's tibia is moved in an anterior direction as compared to the normal anatomical position of the tibia relative to the femur. At least a portion of the hinged connection, which frequently includes the pivot axis, is located posteriorly of portions of the femur proximate the knee joint to maximize the arc through which the knee can be flexed.


David Schurman Photo 9

In Vivo, Ex Vivo And In Vitro Regenerated Cartilage

US Patent:
2003013, Jul 17, 2003
Filed:
Dec 24, 2002
Appl. No.:
10/328387
Inventors:
R. Smith - Palo Alto CA, US
Dennis Carter - Stanford CA, US
David Schurman - Stanford CA, US
International Classification:
C12Q001/68, A61M029/00
US Classification:
424/093700, 424/422000, 435/006000
Abstract:
A method for in vivo, ex vivo and in vitro regeneration of cartilage and collagen. In vivo, ex vivo and in vitro regeneration and de novo formation of articular cartilage and collagen by intermittently applied hydrostatic pressure. The application of external interval loading consisting of repeated periods of applied hydrostatic pressure followed and interrupted by periods of recovery. The application of the intermittent hydrostatic pressure at physiological levels 5-10 MPA for an interval of 4 hours followed by a recovery period up to about 20 hours, said pressure applied to the cartilage cells in vitro, explants of cartilage ex vivo and in vivo to cartilage that remains intact within te joint space of diarthrotic joints. The interval loading results in the selective inhibition of matrix degrading enzymes, pro-inflammatory cytokines and chemokines that attract inflammatory cells into the joint cavity and in selective decrease of gene expression of growth factors that are inhibitory to type II collagen expression.